Table 2.
Urinary PEG probe excretion in basal (placebo) and indomethacin-challenged state
| Basal probe excretion (μmol) | Indomethacin probe excretion (μmol) | P | |||
|---|---|---|---|---|---|
|
|
|
||||
| Median | Range | Median | Range | ||
| PEG 400 (0–1-h urine) | 1487 | (108–8260) | 5795 | (1272–9923) | <0.05 |
| PEG 400 (0–2-h urine) | 1969 | (458–11,013) | 8230 | (2908–12,942) | <0.01 |
| PEG 400 (0–5-h urine) | 4597 | (2081–12,123) | 9893 | (4180–14,808) | <0.01 |
| PEG 1500 (0–1-h urine) | 3.20 | (0.40–318.30) | 35.90 | (6.70–165.90) | 0.20 |
| PEG 1500 (0–2-h urine) | 11.90 | (1.30–383.30) | 111.00 | (22.60–339.60) | <0.05 |
| PEG 1500 (0–5-h urine) | 18.90 | (2.80–386.50) | 174.20 | (35.50–366.10) | 0.05 |
| PEG 3350 (0–1-h urine) | 0.00 | (0.00–8.60) | 0.40 | (0.00–9.80) | 0.67 |
| PEG 3350 (0–2-h urine) | 0.10 | (0.00–10.30) | 1.10 | (0.00–11.50) | 0.20 |
| PEG 3350 (0–5-h urine) | 0.40 | (0.00–10.30) | 1.80 | (0.00–104.00) | <0.05 |
Abbreviations: PEG, polyethylene glycol; h, hour.